Filter Results:
(64)
Show Results For
- All HBS Web
(242)
- News (64)
- Research (134)
- Events (1)
- Multimedia (3)
- Faculty Publications (95)
Show Results For
- All HBS Web
(242)
- News (64)
- Research (134)
- Events (1)
- Multimedia (3)
- Faculty Publications (95)
Sort by
- 01 Jun 2023
- News
Research Brief: The Best Medicine
As it turns out, innovation doesn’t benefit everyone equally, and a new study tries to understand how that plays out in the pharmaceutical R&D process in the United States. “The numbers are striking,” says Associate Professor Joshua Schwartzstein, pointing to the fact... View Details
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
afford these patients a better quality of life for a longer period of time. It could be the first new treatment for ALS in nearly 25 years and the first one to potentially affect muscle function and strength as well as hopefully preserve patient independence.” While... View Details
Keywords: Deborah Blagg
- 23 Aug 2020
- News
In the UK, She Leads the Search for a COVID Vaccine
Oxford University, is also making a plan for when a vaccine does become available. While a small portion of the UK population is staunchly “anti-vax” her primary concern is those who are fearful of how quickly the vaccine is being developed. “The safety of the View Details
- 24 Sep 2020
- News
The Race for a Vaccine
Bingham’s attention is as focused on clinical trial enrollment as it is on, say, cold-chain distribution (some of the vaccines under consideration must be maintained at –122 degrees Fahrenheit). READ MORE In... View Details
- 01 Jun 2018
- News
Floor It
so that we can help get clinical trials done and move the pace of discovery even quicker.” How do they expect to get there? Here, a look at the accelerator’s model, which comprises four work streams, each... View Details
Keywords: Julia Hanna; illustration by Mengxin Li
- 22 Feb 2022
- News
Elevator Pitch: Good Vibrations
breakthrough-device designation from the FDA. This puts OsteoBoost on a fast track for approval following analysis of two clinical trials currently in progress, with a target launch date of early 2023.... View Details
- 16 Sep 2016
- News
Gaining Ground on ALS
If you are one of the 17 million people who participated in the ALS Ice Bucket Challenge, the money you raised may be helping to fund a first-of-its kind clinical collaboration between a nonprofit patient/disease advocacy organization and... View Details
- 26 Feb 2020
- News
Alumni-Led Biotech Developing Vaccine to Combat Coronavirus
in the Wall Street Journal notes that the NIH expects clinical trials to begin in 20 to 25 volunteers by the end of April. Bancel is also part of a wider effort by researchers from Harvard and other local... View Details
- 19 Apr 2016
- News
LuminOva Makes Great Strides Tackling Infertility
towards commercialization. While many businesses enter the Challenge each year and benefit from the mentoring, workshops, and judging process, the winner of the Bertarelli Foundation Grand Prize receives a $40,000 award that moves the firm forward and helps it overcome... View Details
- 28 Feb 2020
- News
Filling the White Space
companies involved in research into psychedelic compounds for medical use. (Compass has been granted a US patent that covers a method of obtaining psilocybin to treat drug-resistant depression; the treatment is in a phase IIb clinical... View Details
- 24 Apr 2014
- News
Giving hope and inspiration to cancer patients around the globe
data and share it globally. The organization also spearheads a clinical network of 16 research centers to conduct early-phase clinical trials faster and more efficiently. By... View Details
- 01 Jun 2020
- News
The Network Effect
didn’t even work—and sent him digging into the larger challenges posed by the pandemic. He soon discovered a gap he knew he could fill: While there was a good deal of clinical research underway, 85 percent of testing, drug, and vaccine... View Details
- 20 Aug 2014
- News
With No Time to Lose
developed a way to measure electrical impulses in muscle tissue, and therefore measure changes in those impulses as the disease progresses. This one achievement can effectively reduce some costs associated with clinical View Details
Keywords: Margie Kelley
- 25 Apr 2014
- News
Bringing a new funding model to the life sciences industry
health care. "It's essentially a form of equity crowdfunding," Farquharson explains. "Since our focus is on breakthroughs in health care, success translates to dramatic improvements in clinical outcomes." Among those companies benefitting... View Details
- 01 Dec 2005
- News
Pedal Mettle
player who was diagnosed with Hodgkin’s disease in 1995, Berté saw the cancer return six months after she completed her initial treatment. She then enrolled in a clinical trial including chemotherapy,... View Details
- 08 Jun 2021
- News
New Funding for Female Founders
Boost VC, SV Angel, Village Global, and Threshold Ventures, according to the Wall Street Journal. Coravos is co-founder and CEO of the startup, formerly known as Elektra Labs, which helps hospitals and pharmaceutical companies employ sensor technologies to move medical... View Details
- 01 Dec 2018
- News
Case Study: Your Data, Your Health
early detection of gynecological diseases. The Oakland-based company completed its second clinical trial and is now raising Series A funding. Its initial indications focus on identifying conditions that... View Details
Keywords: Jen McFarland Flint
- 04 Sep 2019
- News
Accelerating Scientific Discovery
ask their scientists about therapeutics they are developing as their companies grapple with both clinical trial successes and failures. Classes also will focus on the most promising advances, including... View Details
Keywords: Jennifer Gillespie
- 02 Aug 2011
- News
A Fearless Force for Change
founded with her husband Dave Linn (MBA '00) to fund research and clinical trials at Memorial Sloan-Kettering Cancer Center. Linn died July 20 at the age of 40. Diagnosed with a soft-tissue sarcoma (a... View Details
- 04 Sep 2019
- News
Advancing Diagnostics that Can Save Lives
antibiotic susceptibility profiles. The expertise DZD has developed along its three-year journey is already being deployed in clinical settings. “Our goal has always been to be commercially relevant, even during our R&D phase,” notes Lee.... View Details
Keywords: Susan Young